Frequency of Florid Hyperthyroidism In Patients Taking Iodinated Salt

Frequency of Florid Hyperthyroidism In Patients Taking Iodinated Salt: A Cross Sectional Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04809454

Acronym

I2 and thyroid

Enrollment

100

Registered

2021-03-22

Start date

2021-10-31

Completion date

2022-03-31

Last updated

2021-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Dysfunction

Keywords

Thyroid, Iodine

Brief summary

Thyroxin a vital hormone for life lot of body functions depend on proper functioning on pituitary thyroid axis. it exists in two major forms Thyroxine (T4) and (T3) , each of them containing two iodine atoms on their inner (tyrosine) ring. Synthesis of reasonable quantities of thyroid hormones requires adequate iodine intake to allow sufficient thyroidal uptake. The World Health Organization (WHO) recommendation for daily intake of iodine is 150 μg for children ≥12 years and adults, and 250 μg for pregnant and lactating women. However as we know optimum amount of iodine is required for normal pituitary thyroid axis like wise excessive intake may cause over functioning of axis hence over production of hormone that can be manifested both clinically and biochemically. This study is designed to observe the frequency of over hyperthyroidism in patients taking iodinated salt.

Detailed description

All patients presenting to endocrine clinic fulfilling inclusion and exclusion criteria will be recruited. They will be examined, their vitals including blood pressure pulse will be noted, thyroid clinical examination including eye signs and thyroid status will be done biochemical Thyroid profile (TSH, Free T3 & Free T4) will be noted in predesigned proforma. Statistical Analysis will be done ,after data is entered in Statistical Package for the Social Sciences (SPSS) version 25 .qualitative data will be presented as frequencies and percentages while quantitative data will be presented as mean medians and standard deviations.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Inclusion criteria

1. All patients presenting with biochemical hyperthyroidism 2. Who are taking Iodinated salt. 3. Treatment naïve patients 4. Both genders included 5. All patients who can give consent (18-60 years)

Exclusion criteria

1\) Pregnant females 2) Lactating mothers \-

Design outcomes

Primary

Measure	Time frame	Description
Affect of Iodinated Salt on Thyroid Status	through study completion an average of 12 weeks	Affect of Iodinated Salt on Thyroid Status

Countries

Pakistan

Contacts

Primary ContactMehwish Iftikhar, FCPS Endocrinologyy

drmehwish19@gmail.com923004291641

Backup ContactAmna Rizvi, FCPS Endocrinology

amnarizvi512@gmail.com923009463345

Outcome results